Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03345485
Title Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mundipharma-EDO GmbH
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
Stanford University Medical Center Palo Alto California 94304 United States Details
Georgetown University Washington District of Columbia 20007 United States Details
Northwestern University Chicago Illinois 60611 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
New York Univesity New York New York 10016 United States Details
Mary Crowley Cancer Research Dallas Texas 75251 United States Details
McGill University Montréal Quebec H4A 3J1 Canada Details
*Shaded cells indicate that there was no data available from for the field